Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0393754 (
HSA
)
2,996
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A simple fluorescent probe
HBI
-GR based on the combination of the fluorophore (p-HBI) in green fluorescent protein (GFP) and Guanine riboside (GR) for
HSA
was successfully synthesized.
HBI
-GR showed an obvious fluorescence enhancement toward
HSA
without interference from other proteins, amino acids, anions and commonly existing metal ions.
HBI
-GR exhibited high sensitivity towards
HSA
with a good linear relationship between the fluorescence intensity of
HBI
-GR and
HSA
concentration from 0 to 0.06mgmL
-1
. The limit of detection, based on a signal-to-noise ratio of 3, was 15.09ngmL
-1
, which was much lower than that of most other reported probes.
HBI
-GR was almost non-fluorescent because of the bond twisting in the exited state of chromophore
HBI
. After binding to the hydrophobic pocket of
HSA
, it showed an obvious fluorescence enhancement due to the rigidifying of the flexible chromophore
HBI
by the hydrophobic environment. The resulting
HBI
-GR/
HSA
system also showed a satisfactory sensing ability toward trypsin through decreased fluorescence intensity with the detection limit of 0.0282ngmL
-1
. The fluorescence decreasing process was occurred as the lysine and arginine amino acids residues of
HSA
were cleaved by trypsin, which led to further exposure of
HBI
-GR to the PBS buffer phase and a concomitant decrease of the
HBI
-GR fluorescence intensity. Moreover, the probe
HBI
-GR was successfully used to detect
HSA
in healthy human urine and human blood serum samples. The practical application of the
HBI
-GR/
HSA
system for trypsin detection in healthy human urine also achieved satisfactory result.
...
PMID:A selective and sensitive fluorescent probe for the determination of HSA and trypsin. 2850 Dec 12